Alfei, Francesca
Ho, Ping-Chih http://orcid.org/0000-0003-3078-3774
Lo, Wan-Lin http://orcid.org/0000-0002-9074-6847
Article History
Received: 28 April 2021
Revised: 29 June 2021
Accepted: 6 July 2021
First Online: 21 July 2021
Competing interests
: AF and W-LL declare no conflicts of interest. P-CH is a scientific advisor for Elixiron Immunotherapeutics, Novartis, and Acepodia. P-CH also received research support from Elixiron Immunotherapeutics.